• Kolli Sravani
  • Dharavatu Priyanka School of Pharmaceutical Sciences & Technologies, Jawaharlal Nehru Technological University, Kakinada, Andhra Pradesh, India.
  • R. Sravani
  • K. Srinivas Reddy
  • D. Vinay Kumar


Vildagliptin belongs to a class of orally active anti-diabetic drug which inhibits dipeptidyl peptidase-4(DPP-4) and to potentiate the secretion of insulin in the β-cells, there by decreasing blood glucose level. Vildagliptin is a short half life drug so it needs to formulate into sustained release dosage form to reduce dose frequency for patient compliance. Among various techniques, formulation of matrix tablets using matrix formers is a simple and industrially useful technique in the design of sustained release drug delivery systems. In the present study, an attempt has been made to develop sustained release matrix tablets of Vildagliptin using hydrophilic polymers like HPMC (k15M, K100M) and Carbapol by using wet granulation method. Dissolution study was done by using type-II dissolution apparatus gave good results with combination of HPMC K100 M and Carbapol. Drug release from the formulation follows zero order, first order, Higuchi’s equation, and korsemeyer’s equation.

Keywords: Vildagliptin, Anti-diabetic drug, Sustained release dosage form, Matrix formers, Wet granulation. 


1. Lee VHL. Controlled Drug Delivery Fundamentals and Applications: Influence of drug properties on design, Marcel Dekker, (2nded) INC: New York; 1987. p. 16-29.
2. JR Robinson, HL Lee. “Controlled drug delivery: Fundamentals and Applications”, Second edition. Marcel Dekker 2005;5(6):255-9, 374, 375.
3. Marshall L. Lachman HA. Leon Liberman, JL Kanig. The Theory and practice of industrial pharmacy, Varghese publishing house. Bombay 1987;3:66-99.
4. Paulo Costa, Jose Manuel Sousa Lobo. “Modeling and Comparison of Dissolution Profiles”. Eur J Pharm Sci 2001. p. 123-33.
5. Suvakanta Dash, Padala Darasimha Murthy, Lila kanta nath. Prasanta chowdary-kinetic modelling on drug release from controlled drug delivery systems. Acta Polonia Pharm drug Res 2010;67(3):217-23.
6. Carstensen JT, Rhodes CT. Drug stability-principles and practices 3rd ed. Marcel Dekker; 2000. p. 16-8.
7. World Health Organization WHO Technical Report Series. Annex 2 Stability testing of active pharmaceutical ingredients and finished pharmaceutical products; 2009. p. 953.
8. Sunil Kamboj. Matrix tablets: an Important Tool for Oral Controlled Release Dosage forms. Pharm info 2009;7(6):12-24.
1358 Views | 1054 Downloads
How to Cite
Sravani, K., D. Priyanka, R. Sravani, K. Reddy, and D. Kumar. “FORMULATION AND EVALUATION OF VILDAGLIPTIN SUSTAINED RELEASE MATRIX TABLETS”. International Journal of Current Pharmaceutical Research, Vol. 6, no. 4, 1, pp. 69-75,
Original Article(s)